102767-28-2;51052-62-1 Levetiracetam
| 상품명칭 |
Levetiracetam |
| 영문 이름 |
Levetiracetam; (s)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-1-pyrrolidineacetamid; (+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; 1-Pyrrolidineacetamide; alpha-ethyl-2-oxo-; alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetamum [INN-Latin]; Keppra; Levetiracetam [INN]; Levetiracetamum [INN-Latin]; LEVITIRACETAM; UCB 6474; UCB-6474; UCB-L 059; Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam); (2R)-2-(2-oxopyrrolidin-1-yl)butanamide; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; Levetiracetame |
| 분자식 |
C8H14N2O2 |
| 분자량 |
170.209 |
| InChI |
InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1 |
| cas번호 |
102767-28-2;51052-62-1 |
| 분자 구조 |
|
| 밀도 |
1.168g/cm3 |
| 녹는 점 |
118-119℃ |
| 비등점 |
395.9°C at 760 mmHg |
| 굴절 지수 |
1.518 |
| 인화점 |
193.2°C |
| 증기압 |
1.78E-06mmHg at 25°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
